OPC Pharmaceutical

OPC

VN000000OPC9

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
24,000 ^VND	+2.56%		+2.13%	-.--%

05-13	Opc Pharmaceutical Joint Stock Company Appoints Nong Thi Lan as Member of the Internal Audit Committee	CI
05-06	OPC Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2023, Payable on May 21, 2024	CI

OPC Pharmaceutical Joint Stock Company Elect Members of the Board of Directors and Members of the Board of Supervisors

October 26, 2021 at 05:02 am

On October 22, 2021, OPC Pharmaceutical Joint Stock Company ?announced the Resolution of the extraordinary general shareholders? meeting (EGM) as: approving to elect members of the BOD in the term 2021 ? 2026: Trinh Xuan Vuong; Le Van Son; Han Thi Khanh Vinh; Phuong Thanh Nhung and Nguyen Hai Duong. Approving to elect members of the Board of Supervisors in the term 2021 ? 2026: Nguyen Thi Hong Nhung; Kieu Thi Minh Hong and Nguyen Trung Thanh.

Latest news about OPC Pharmaceutical

Opc Pharmaceutical Joint Stock Company Appoints Nong Thi Lan as Member of the Internal Audit Committee	05-13	CI
OPC Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2023, Payable on May 21, 2024	05-06	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	05-01	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	01-29	CI
OPC Pharmaceutical Joint Stock Company Receives the Resignation from Duong Minh Hung as Sales and Marketing Deputy Chief Executive Officer	12-05	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/10/23	CI
OPC Pharmaceutical Joint Stock Company Appoints Mrs. Nguyen Thi Hong the Person in Charge of Corporate Governance Cum Secretary	29/08/23	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/07/23	CI
OPC Pharmaceutical Joint Stock Company Announces the Resignation of Le Van Son as Chairman of the BOD	25/05/23	CI
OPC Pharmaceutical Joint Stock Company Announces the Remaining Cash Dividend in 2023, Payable on May 25, 2023	08/05/23	CI
Opc Pharmaceutical Joint Stock Company Announces Executive Changes	05/05/23	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23	CI
OPC Pharmaceutical Joint Stock Company Approves to Pay the First Cash Dividend for 2022, Payment Date: April 26, 2023	30/03/23	CI
OPC Pharmaceutical Joint Stock Company Announces Management Resignations	20/03/23	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	27/01/23	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	27/01/23	CI
OPC Pharmaceutical Joint Stock Company Appoints Phuong Thanh Nhung as Deputy Chairman of the Board of Director	22/12/22	CI
OPC Pharmaceutical Joint Stock Company Appoints Duong Minh Hung as Deputy CEO	17/11/22	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/10/22	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/07/22	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	27/01/22	CI
OPC Pharmaceutical Joint Stock Company Announces Establishment of the Audit Committee and Risk Management	09/12/21	CI
Opc Pharmaceutical Joint Stock Company Approves First Cash Dividend for 2021, Payable on March 15, 2022	08/12/21	CI
OPC Pharmaceutical Joint Stock Company Elect Members of the Board of Directors and Members of the Board of Supervisors	26/10/21	CI

Chart OPC Pharmaceutical

Duration

Period

More charts

Company Profile

OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
OPC PHARMACEUTICAL	-.--%	60.41M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B